339 related articles for article (PubMed ID: 21175662)
1. Antibody-mediated (immune) transfusion-related acute lung injury.
Bux J
Vox Sang; 2011 Jan; 100(1):122-8. PubMed ID: 21175662
[TBL] [Abstract][Full Text] [Related]
2. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
Reil A; Keller-Stanislawski B; Günay S; Bux J
Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
[TBL] [Abstract][Full Text] [Related]
3. Frequency and severity of transfusion-related acute lung injury--German haemovigilance data (2006-2007).
Keller-Stanislawski B; Reil A; Günay S; Funk MB
Vox Sang; 2010 Jan; 98(1):70-7. PubMed ID: 19671122
[TBL] [Abstract][Full Text] [Related]
4. Screening of multiparous women to avoid transfusion-related acute lung injury: a single centre experience.
Sachs UJ; Link E; Hofmann C; Wasel W; Bein G
Transfus Med; 2008 Dec; 18(6):348-54. PubMed ID: 19140817
[TBL] [Abstract][Full Text] [Related]
5. Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody-mediated transfusion-related acute lung injury.
; Bierling P; Bux J; Curtis B; Flesch B; Fung L; Lucas G; Macek M; Muniz-Diaz E; Porcelijn L; Reil A; Sachs U; Schuller R; Tsuno N; Uhrynowska M; Urbaniak S; Valentin N; Wikman A; Zupanska B
Vox Sang; 2009 Apr; 96(3):266-9. PubMed ID: 19207164
[TBL] [Abstract][Full Text] [Related]
6. How much residual plasma may cause TRALI?
Win N; Chapman CE; Bowles KM; Green A; Bradley S; Edmondson D; Wallis JP
Transfus Med; 2008 Oct; 18(5):276-80. PubMed ID: 18937733
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of transfusion-related acute lung injury (TRALI): anti-leukocyte antibodies.
Curtis BR; McFarland JG
Crit Care Med; 2006 May; 34(5 Suppl):S118-23. PubMed ID: 16617255
[TBL] [Abstract][Full Text] [Related]
8. Relationship of donor HLA antibody strength to the development of transfusion-related acute lung injury.
Hashimoto S; Nakajima F; Kamada H; Kawamura K; Satake M; Tadokoro K; Okazaki H
Transfusion; 2010 Dec; 50(12):2582-91. PubMed ID: 20667042
[TBL] [Abstract][Full Text] [Related]
9. Reducing the incidence of TRALI in the UK: the results of screening for donor leucocyte antibodies and the development of national guidelines.
Lucas G; Win N; Calvert A; Green A; Griffin E; Bendukidze N; Hopkins M; Browne T; Poles A; Chapman C; Massey E
Vox Sang; 2012 Jul; 103(1):10-7. PubMed ID: 22150747
[TBL] [Abstract][Full Text] [Related]
10. Allo-exposure status and leucocyte antibody positivity of blood donors show a similar relation with TRALI.
Middelburg RA; Beckers EA; Porcelijn L; Lardy N; Wiersum-Osselton JC; Schipperus MR; Vrielink H; Briët E; van der Bom JG
Transfus Med; 2012 Apr; 22(2):128-32. PubMed ID: 22380759
[TBL] [Abstract][Full Text] [Related]
11. Blood donors implicated in transfusion-related acute lung injury with patient-specific HLA antibodies are more broadly sensitized to HLA antigens compared to other blood donors.
Saw CL; Hannach B; Petrazsko T; Nickerson P
Transfusion; 2013 Mar; 53(3):518-25. PubMed ID: 22738429
[TBL] [Abstract][Full Text] [Related]
12. TRALI-new challenges for histocompatibility and immunogenetics in transfusion medicine.
Flesch BK; Petershofen EK; Bux J
Tissue Antigens; 2011 Jul; 78(1):1-7. PubMed ID: 21658007
[TBL] [Abstract][Full Text] [Related]
13. Transfusion-related acute lung injury: current concepts for the clinician.
Triulzi DJ
Anesth Analg; 2009 Mar; 108(3):770-6. PubMed ID: 19224781
[TBL] [Abstract][Full Text] [Related]
14. Antibody-mediated transfusion-related acute lung injury; from discovery to prevention.
Peters AL; Van Stein D; Vlaar AP
Br J Haematol; 2015 Sep; 170(5):597-614. PubMed ID: 25921271
[TBL] [Abstract][Full Text] [Related]
15. Anti-human neutrophil antigen-3a induced transfusion-related acute lung injury in mice by direct disturbance of lung endothelial cells.
Bayat B; Tjahjono Y; Sydykov A; Werth S; Hippenstiel S; Weissmann N; Sachs UJ; Santoso S
Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2538-48. PubMed ID: 24008160
[TBL] [Abstract][Full Text] [Related]
16. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
Porretti L; Cattaneo A; Coluccio E; Mantione E; Colombo F; Mariani M; Bottelli G; Mazzucchelli S; Pappalettera M; Speranza T; Migliari M; Cambié G; Prati D; Rebulla P
Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
[TBL] [Abstract][Full Text] [Related]
17. Transfusion related acute lung injury (TRALI) caused by red blood cell transfusion involving residual plasma anti-HLA antibodies: a report on two cases and general considerations.
Odent-Malaure H; Quainon F; Ruyer-Dumontier P; Ducroz S; Verdier P; Voitellier E; Raynal MF; Fromont P; Muller JY; Rebibo D; Absi L; Garraud O
Clin Dev Immunol; 2005 Dec; 12(4):243-8. PubMed ID: 16584109
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of leucocyte antibodies in the Dutch donor population.
Middelburg RA; Porcelijn L; Lardy N; Briët E; Vrielink H
Vox Sang; 2011 Apr; 100(3):327-35. PubMed ID: 20946548
[TBL] [Abstract][Full Text] [Related]
19. Transfusion-related acute lung injury: Current understanding and preventive strategies.
Vlaar AP
Transfus Clin Biol; 2012 Jun; 19(3):117-24. PubMed ID: 22682310
[TBL] [Abstract][Full Text] [Related]
20. [Transfusion-related acute lung injury].
Vlaar AP; Juffermans NP
Ned Tijdschr Geneeskd; 2013; 157(11):A5524. PubMed ID: 23484511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
